ArticleApplied biochemistry and biotechnology2026
DNA Methylation Patterns of 5mC Regulators: Insights into Immune Microenvironment Regulation in Heart Failure.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The 5-methylcytosine (5mC) epigenetic modification is a prominent pattern of DNA methylation. Nonetheless, its function and relationship with the immune microenvironment (IME) in heart failure (HF) are unclarified. Firstly, seven microarrays and two high-throughput sequencing datasets were downloaded from GEO for this research. Secondly, random forests, LASSO logistic regression, and SVM-RFE were leveraged for screening hub genes. Quantitative PCR, Western blot, and immunofluorescence staining were conducted in a male rat model of HF after myocardial infarction for validation. Thirdly, 5mC-related HF samples were allocated into two distinct categories using consensus clustering algorithms. Finally, single-sample gene-set enrichment analysis and CIBERSORT deconvolution algorithm were utilized for further exploring the IME in HF, including infiltrating immune cell abundance score, human leukocyte antigen (HLA), and immune checkpoints (ICPs). Among these 5mC regulators, four hub genes were uncovered, and the diagnostic model exhibited an outstanding ability to distinguish HF and healthy samples (0.969, 95%CI, 0.953-0.985). DNMT3B was identified as greatly influencing cardiac function. DNMT3B and MBD2 were finally identified as hub genes in the HF model. Two 5mC subtypes manifested different modification patterns, infiltrating immunocytes, ICPs, and HLA gene expression. Furthermore, 305 DEGs were found in 5mC subtypes, and many functions were associated with important pathophysiological mechanisms of HF. The HF diagnostic model was established using 5mC robust core biomarkers. 5mC methylation regulators may offer novel perspectives for understanding the mechanisms, accurate diagnosis, and effective interventions for HF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.